Flagship Private Wealth, LLC Gilead Sciences, Inc. Transaction History

Flagship Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $2,436 - $2,629	-36 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$63.47 - $69.35 $155,057 - $169,422	-2,443 Reduced 98.55%	36 $2.48 Million
Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $155,057 - $169,422	2,443 Added 6786.11%	2,479 $170,000
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $2,039 - $2,323	36 New	36 $2,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.